Effects of (R,R)- and (R,R/S,S)-Formoterol on Airway Relaxation and Contraction in an Experimental Rat Model

Current Therapeutic Research - Clinical and Experimental

Volumn 68, Issue 4, 2007, Pages 249-261

  Mhanna, Maroun J ^a   Koester, Jeffrey F ^b   Cohn, Robert C ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

(R,R) formoterol; (R,R S,S) formoterol; airway contraction; airway relaxation; electrical field stimulation

Indexed keywords

BETHANECHOL; FORMOTEROL;

AIRWAY CONSTRICTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; INCUBATION TIME; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY SYSTEM; TRACHEA;

EID: 34748888269     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2007.08.005     Document Type: Article

References (30)

1. Nelson H., Bensch G., Pleskow W., et al. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol. 102 (1998) 943-952
2. Templeton A., Chapman I., Chilvers E., et al. Effects of S-salbutamol on human isolated bronchus. [published correction appears in Pulm Pharmacol Ther. 1998;11:243]. Pulm Pharmacol Ther. 11 (1998) 1-6
3. Mitra S., Ugur M., Ugur O., et al. (S)-Albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in air-way smooth muscle. Mol Pharmacol 53 (1998) 347-354
4. Agrawal D., Ariyarathna K., and Kelbe P. (S)-Albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells. J Allergy Clin Immunol 113 (2004) 503-510
5. Ameredes B., and Calhoun W. Modulation of GM-CSF release by enantiomers of β-agonists in human airway smooth muscle. J Allergy Clin Immunol 116 (2005) 65-72
6. Finkel M., Quirion R., Pert C., and Patterson R. Characterization and autoradiographic distribution of the 3-adrenergic receptor in the rat lung. Pharmacology 29 (1984) 247-254
7. Denis D., Fayon M., Berger P., et al. Prolonged moderate hyperoxia induces hyper-responsiveness and airway inflammation in newborn rats. Pediatr Res. 50 (2001) 515-519
8. 2-adrenoceptor agonists is related to attenuated expression of postjunctional smooth muscle muscarinic M2 receptors. J Appl Physiol 98 (2005) 1526-1533
9. Mhanna M., Dreshaj I., Haxhiu M., and Martin R. Mechanism for substance P-induced relaxation of precontracted airway smooth muscle during development. Am J Physiol. 276 (1999) L51-L56
10. Szarek J., Stewart N., Spurlock B., and Schneider C. Sensory nerve- and neuropeptide-mediated relaxation responses in airways of Sprague-Dawley rats. J Appl Physiol 78 (1995) 1679-1687
11. Handley D., Senanayake C., Dutczak W., et al. Biological actions of formoterol isomers. Pulm Pharmacol Ther 15 (2002) 135-145
12. Schmidt D., Kallstrom B., Waldeck B., et al. The effect of the enantiomers of formoterol on inherent and induced tone in guinea-pig trachea and human bronchus. Naunyn Schmiedebergs Arch Pharmacol 361 (2000) 405-409
13. 2-Adrenoceptor agonists inhibit NANC neural bronchoconstrictor responses in vitro. J Appl Physiol 74 (1993) 1195-1199
14. Barnes P. Modulation of neurotransmission in airways. Physiol Rev 72 (1992) 699-729
15. 2-adrenoceptors. J Appl Physiol. 65 (1988) 700-705
16. 2-agonists on ACh release and smooth muscle contraction in the trachea. Am J Physiol 274 (1998) L32-L38
17. Keir S., Page C., and Spina D. Bronchial hyperresponsiveness induced by chronic treatment with albuterol: Role of sensory nerves. J Allergy Clin Immunol 110 (2002) 388-394
18. 2-selective sympathomimetics. Pulm Pharmacol 7 (1994) 367-376
19. Bergendal A., Linden A., Lotvall J., et al. Different effects of salmeterol, formoterol and salbutamol on cholinergic responses in the ferret trachea. Br J Pharmacol 114 (1995) 1478-1482
20. Berger W., Ames D., and Harrison D. A patient satisfaction survey comparing levalbuterol with racemic albuterol in children. Allergy Asthma Proc 25 (2004) 437-444
21. Carl J., Myers T., Kirchner H., and Kercsmar C. Comparison of racemic albuterol and levalbuterol for treatment of acute asthma. J Pediatr. 143 (2003) 731-736
22. Milgrom H., Skoner D., Bensch G., et al., Levalbuterol Pediatric Study Group. Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol. J Allergy Clin Immunol. 108 (2001) 938-945
23. Nowak R., Emerman C., Hanrahan J., et al., XOPENEX Acute Severe Asthma Study Group. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. Am J Emerg Med. 24 (2006) 259-267
24. Schreck D., and Babin S. Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED. Am J Emerg Med 23 (2005) 842-847
25. Hardasmalani M., DeBari V., Bithoney W., and Gold N. Levalbuterol versus racemic albuterol in the treatment of acute exacerbation of asthma in children. Pediatr Emerg Care 21 (2005) 415-419
26. Ralston M., Euwema M., Knecht K., et al. Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: A randomized controlled trial. J Emerg Med 29 (2005) 29-35
27. Qureshi F., Zaritsky A., Welch C., et al. Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. Ann Emerg Med 46 (2005) 29-36
28. Thompson M., Wise S., and Rodenberg H. A preliminary comparison of levalbuterol and albuterol in prehospital care. J Emerg Med 26 (2004) 271-277
29. Hamid Q., Mak J., Sheppard M., et al. Localization of [32-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: Correlation with receptor autoradiography. Eur J Pharmacol 206 (1991) 133-138
30. Vornanen M. Adrenergic responses in different sections of rat airways. Acta Physiol Scand 114 (1982) 587-591